02:52 PM EDT, 07/03/2024 (MT Newswires) -- Valerie Morisset, Executive Vice President, Research and Development and Chief Scientific Officer, on July 01, 2024, sold 50,000 shares in Eliem Therapeutics ( ELYM ) for $338,000. Following the Form 4 filing with the SEC, Morisset has control over a total of 462,956 shares of the company, with 462,956 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1768446/000141588924019147/xslF345X03/form4-07032024_060700.xml

Price: 6.86, Change: +0.05, Percent Change: +0.73